Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

<p style="text-align:justify;"> <b>Objectives:</b> This study sought to examine the effect of statin therapy hospitalizations for heart failure (HFH) in patients in the CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) trial.<br/><br/> <...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Rogers, J, Jhund, P, Perez, A, Böhm, M, Cleland, J, Gullestad, L, Kjekshus, J, Van Veldhuisen, D, Wikstrand, J, Wedel, H, McMurray, J, Pocock, S
Format:	Journal article
Sprog:	English
Udgivet:	Elsevier 2014

Lignende værker

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
af: Erik Tandberg Askevold, et al.
Udgivet: (2015-01-01)

Rosuvastatin in older patients with systolic heart failure.
af: Florkowski, C, et al.
Udgivet: (2008)

Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis
af: Kotecha, D, et al.
Udgivet: (2017)

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
af: Cleland, J, et al.
Udgivet: (2017)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
af: Gounari, P, et al.
Udgivet: (2010)

Rosuvastatin safety and efficacy in coronary heart disease patients
af: I. V. Sergienko, et al.
Udgivet: (2006-10-01)

Eplerenone in patients with systolic heart failure and mild symptoms
af: Rogers, J, et al.
Udgivet: (2012)

Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin
af: Melissa Cintra, et al.
Udgivet: (2023-05-01)

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
af: Tousoulis, D, et al.
Udgivet: (2010)

Perioperative rosuvastatin in cardiac surgery
af: Zheng, Z, et al.
Udgivet: (2016)

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products
af: Jure Zakrajšek, et al.
Udgivet: (2017-12-01)

The Antimycotic Activity of Rosuvastatin
af: Zahraa Qasim
Udgivet: (2022-12-01)

Current perspectives on rosuvastatin
af: Hu M, et al.
Udgivet: (2013-04-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
af: S. R. Gilyarevsky
Udgivet: (2015-12-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
af: S. R. Gilyarevsky
Udgivet: (2015-12-01)

Rosuvastatin-Induced reversible rhabdomyolysis
af: Sangeeta Pradhan, et al.
Udgivet: (2023-01-01)

Rosuvastatin induced photolocalized purpura
af: Marwa Thabouti, et al.
Udgivet: (2022-09-01)

Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
af: Sang-Hyeon Ju, et al.
Udgivet: (2024-03-01)

The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
af: Venkata Narla, et al.
Udgivet: (2009-11-01)

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.
af: Kaspar Broch, et al.
Udgivet: (2014-01-01)

The year in cardiology: heart failure. The year in cardiology 2019
af: J.G.F. Cleland, et al.
Udgivet: (2020-04-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
af: V. V. Kukharchuk, et al.
Udgivet: (2013-06-01)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
af: Lijun Wang, et al.
Udgivet: (2018-06-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
af: Anikin G.S., et al.
Udgivet: (2017-11-01)

Analysis of genetic aspects of therapy with Rosuvastatin
af: Samat Kozhakhmetov, et al.
Udgivet: (2016-06-01)

Preparation and optimization of microemulsion of rosuvastatin calcium
af: B Zalak Patel, et al.
Udgivet: (2012-01-01)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
af: Paolo Rubba, et al.
Udgivet: (2009-04-01)

Debate: Statins should be used in patients with heart failure
af: Kjekshus John
Udgivet: (2001-11-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
af: Sandeep Joshi, et al.
Udgivet: (2017-12-01)

Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales
af: Emdin, C, et al.
Udgivet: (2016)

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)
af: Kristensen, S, et al.
Udgivet: (2017)

Rethinking heart failure clinical trials: the heart failure collaboratory
af: Mutaz Alkalbani, et al.
Udgivet: (2024-01-01)

P5.04 EFFECT OF ROSUVASTATIN ON THE ECHOLUCENCY OF THE COMMON CAROTID INTIMA–MEDIA THICKNESS: THE METEOR TRIAL
af: L. Lind, et al.
Udgivet: (2011-11-01)

Characteristics of heart failure managed in primary care in Europe: the IMPROVEMENT of heart failure survey
af: Cleland, J, et al.
Udgivet: (2001)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
af: Dickstein, K, et al.
Udgivet: (2010)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
af: Dickstein, K, et al.
Udgivet: (2010)

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
af: Kotecha, D, et al.
Udgivet: (2016)

Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS
af: Shi Zhang, et al.
Udgivet: (2020-11-01)

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM‐Preserved
af: Rogers, J, et al.
Udgivet: (2013)

Perioperative rosuvastatin in cardiac surgery - Author's reply
af: Casadei, B, et al.
Udgivet: (2016)